With Key US Patent Upheld, Benitec Sets Sights on ‘Relaunch,’ $8.4M Financing

With Key US Patent Upheld, Benitec Sets Sights on ‘Relaunch,’ $8.4M Financing
Roughly five months after the US Patent and Trademark Office ended a years-long review of Benitec’s core patent, the Australian company announced that it is aiming to raise A$8 million ($8.4 million) though a public offering in order to support development of its three drug-development programs.